New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 19, 2014
08:13 EDTADHD, JPMAlcobra appoints Dr. Tomer Berkovitz as CFO
Alcobra (ADHD) announced that it has appointed Dr. Tomer Berkovitz as CFO, effective May 1. Alcobra also announced that effective May 1, Mr. Udi Gilboa will step down as Acting CFO to pursue other interests. Gilboa will continue to serve as a director of Alcobra. Dr. Berkovitz joins Alcobra after six years at J.P. Morgan (JPM), most recently as an executive director in its corporate finance advisory group.
News For ADHD;JPM From The Last 14 Days
Check below for free stories on ADHD;JPM the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 2, 2014
08:27 EDTADHDAlcobra enrolls first patient in Phase IIb clinical trial
Alcobra announced that the first patient has been enrolled in a Phase IIb study of MDX in adolescents with ADHD. The trial is expected to complete enrollment and report topline data by the end of 2014. The Phase IIb trial is a multi-center, randomized, double-blind, fixed dose study designed to evaluate the safety and tolerability of MDX in up to 82 adolescents with predominantly inattentive ADHD. The primary endpoint will be safety, tolerability and pharmacokinetics.
August 29, 2014
06:49 EDTJPMJPMorgan cyber attack said to occur over months, Bloomberg says
Subscribe for More Information
August 28, 2014
08:12 EDTJPMJPMorgan says not seeing 'unusual fraud,' safeguarding information, WSJ reports
Subscribe for More Information
05:55 EDTJPMHackers targeted JPMorgan Chase, 'at least' four other banks, NY Times reports
According to four sources, JPMorgan Chase and "at least" four others were targeted by hackers in a series of attacks this month, the New York Times reports. Hackers infiltrated the computer networks of some banks and stole checking and savings account information from clients, two separate sources say. Security experts and government officials say it is unclear whether Russian hackers are to blame for the attacks. Reference Link
August 27, 2014
15:37 EDTJPMFBI investigating whether Russia involved with JPMorgan hacking, Bloomberg says
Subscribe for More Information
15:20 EDTJPMHackers stole data from JPMorgan, another U.S. bank this month, Bloomberg says
08:00 EDTJPMSEC seen completing rules on MBS detail disclosures, WSJ says
The Securities and Exchange Commission is expected to complete rules requiring banks and other financial institutions to give investors greater detail about the quality of mortgages and other loans pooled into bonds known as asset-backed securities, reported The Wall Street Journal. Publicly traded big U.S banks include Bank of America (BAC), Citigroup (C), Goldman Sachs (GS), JPMorgan (JPM), Morgan Stanley (MS), U.S. Bancorp (USB) and Wells Fargo (WFC). Reference Link
06:25 EDTADHDAlcobra initiated with a Market Perform at FBR Capital
Subscribe for More Information
August 21, 2014
08:31 EDTJPMMorgan Stanley, JP Morgan selected by Shake Shack to lead IPO, Reuters says
JP Morgan (JPM) and Morgan Stanley (MS) have been picked by Shake Shack to lead the fast-food restaurant chain's IPO, sources tell Reuters. The offering could come as early as this year. Reference Link
06:43 EDTJPMRegulators up bank warning efforts for poor risk assessment, Reuters says
Subscribe for More Information
August 20, 2014
18:29 EDTJPMBofA, JPMorgan weigh plans to raise salaries for junior bankers, Bloomberg says
Subscribe for More Information
August 19, 2014
08:05 EDTADHDAlcobra announces enrollment of first patient in Phase IIb clinical trial of MDX
Alcobra announced that the first patient has been enrolled in a Phase IIb Fragile X study of MDX. The FDA granted "Orphan Drug" designation to Metadoxine in the treatment of Fragile X Syndrome in December 2013. The Phase IIb Fragile X trial is a multi-center, randomized, placebo-controlled study and is being conducted in 11 clinical sites, primarily in the U.S. It is designed to investigate MDX for 6 weeks compared with placebo in 60 adolescent and adult subjects with Fragile X Syndrome.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use